We are live on ! Find out more
VXRT

Vaxart

Delisted

VXRT was delisted on the 7th of July, 2025.

111 hedge funds and large institutions have $21.1M invested in Vaxart in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 19 increasing their positions, 36 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

302% more call options, than puts

Call options by funds: $189K | Put options by funds: $47K

13% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 23

2% more funds holding

Funds holding: 109111 (+2)

3.79% less ownership

Funds ownership: 25.13%21.34% (-3.8%)

18% less capital invested

Capital invested by funds: $25.8M → $21.1M (-$4.64M)

47% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 36

Holders
111
Holders Change
+2
Holders Change %
+1.83%
% of All Funds
1.74%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
26
Increased
19
Reduced
36
Closed
23
Calls
$189K
Puts
$47K
Net Calls
+$142K
Net Calls Change
-$17K

VXRT Hedge Fund Activity: Q2 2023 in Review

111 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q2 2023, worth a combined $21.1M — down 18% from $25.8M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new VXRT positions and 23 closed out — a net gain of 3 holders — while 19 added to existing stakes and 36 trimmed.

The largest buyer was Cantor Fitzgerald, opening a new position worth an estimated $6.59M. The largest seller was BlackRock, cutting an estimated $6.4M.

  • 111 institutional investors held Vaxart (VXRT) as of Q2 2023, up from 109 in Q1 2023.
  • Funds reported $21.1M of Vaxart stock for Q2 2023, down 18% quarter-over-quarter.
  • 26 funds opened new Vaxart positions in Q2 2023 and 23 closed out, a net change of +3 holders.
  • The largest Vaxart buyer in Q2 2023 was Cantor Fitzgerald, an estimated $6.59M added.
  • The largest Vaxart seller in Q2 2023 was BlackRock, an estimated $6.4M sold.

Based on aggregated 13F filings for Q2 2023.